AMAG Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 53 U.S.-traded ETFs. AMAG has around 6.6M shares in the U.S. ETF market. The largest ETF holder of AMAG is the iShares Core S&P Small-Cap ETF (IJR), with approximately 1.62M shares. Investors may also find of interest that the ETF with the largest allocation to AMAG stock is USCF SummerHaven SHPEI Index Fund (BUY), with a portfolio weight of 0.39%. On average, U.S. ETFs allocate 0.07% of AMAG to their portfolios.
Additionally, AMAG is a favorite stock for Vanilla and Fundamental ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with AMAG as a holding is the ALPS Medical Breakthroughs ETF (SBIO), with a return of 19.89%.